Related Experiment Videos
[Congenital tuberculosis in a premature infant]
H G Limbach1, H J Jesberger, G Löffler
1Universitätsklinik für Kinder- und Jugendmedizin Homburg/Saar.
Klinische Padiatrie
|January 1, 1993
Summary
Congenital tuberculosis in a premature infant was diagnosed via stomach secretion analysis. Treatment with isoniazid and rifampicin successfully cured the infection, despite streptomycin resistance and developing cholestasis.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatric Tuberculosis
Background:
- Congenital tuberculosis is a rare but severe condition in newborns.
- Early diagnosis and prompt treatment are crucial for patient survival.
Observation:
- A premature infant (31 weeks gestation, 1300g) presented with suspected congenital tuberculosis at 5 days old.
- Mycobacterium tuberculosis was identified in gastric aspirates, correlating with abdominal symptoms and anemia.
Findings:
- The infant received a 3-month dual parenteral therapy (isoniazid and rifampicin) followed by 6 months of isoniazid monotherapy.
- The tuberculosis was successfully treated, although the Mycobacterium tuberculosis strain developed resistance to streptomycin.
- Cholestasis emerged as a complication during the initial phase of chemotherapy.
Implications:
- This case highlights the importance of considering congenital tuberculosis in at-risk neonates.
- Effective treatment regimens for congenital tuberculosis can be achieved with appropriate antibiotic selection.
- Monitoring for drug resistance and treatment-related complications like cholestasis is essential.